Loading...

Home
ETF
APLS

APLS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

APLS News

RTW Investments Acquires Stake in Apellis Pharmaceuticals

Mar 22 2026Fool

RTW Investments Acquires Stake in Apellis Pharmaceuticals

Mar 22 2026NASDAQ.COM

RTW Investments Takes New Stake in Apellis Pharmaceuticals

Mar 22 2026Yahoo Finance

Roth Capital Initiates Buy on Apellis Pharmaceuticals with $31 Target

Mar 13 2026seekingalpha

Rising Oil Prices Trigger Inflation Concerns

Mar 13 2026Yahoo Finance

Apellis (APLS) Q4 2025 Earnings Call Transcript

Feb 25 2026NASDAQ.COM

Apellis Pharmaceuticals Reports Q4 2025 Financial Results

Feb 24 2026seekingalpha

Apellis Pharmaceuticals Set to Announce Q4 Earnings on February 24

Feb 23 2026seekingalpha

Wall Street Analysts Adjust Ratings

Jan 28 2026Benzinga

Apellis Pharmaceuticals' Empaveli Approved, Projected $508 Million Sales by 2033

Jan 21 2026Benzinga

Bank of America Upgrades Apellis Pharmaceuticals to Buy, Highlights Strong Empaveli Launch

Jan 21 2026seekingalpha

Sobi Secures EU Approval for Aspaveli in Rare Kidney Disorders

Jan 16 2026seekingalpha

Wall Street Trades Cautiously as CPI Rises 2.7% Amid Weak Earnings Reports

Jan 13 2026Benzinga

Telsey Raises Five Below Inc Price Target to $240

Jan 13 2026Benzinga

Gold and Silver Hit Record Highs as Investors Reassess Fed Independence Amid Political Tensions

Jan 12 2026Benzinga

APLS and SOUN Options Show Significant Volume Surge

Jan 09 2026NASDAQ.COM